Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial.
Yoshito OgiharaNorikazu YamadaDaisuke IzumiYuichi SatoToru SatoHitoshi NakayaTatsuya MoriSatoshi OtaMidori MakinoToru OguraSatoshi TamaruYuki NishimuraTakashi TanigawaAtsunobu KasaiMasakatsu NishikawaKaoru Dohinull nullPublished in: Research and practice in thrombosis and haemostasis (2024)
Preliminary data suggest that rivaroxaban may reduce the risk of VTE recurrence among this patient subset, albeit with an increased incidence of bleeding events.